Targeting Protein Interaction in Blood Cancer Cells for Leukemia Treatment

🔬 Anna Orlova is developing new therapeutics against blood cancer, specifically acute myeloid leukemia.

🧪 She and her team have developed a unique screening system to search for novel drugs.

💊 They are working on developing first-in-class inhibitors to target STAT5 oligomerization and treat acute myeloid leukemia.

🎯 The goal is to develop a unique and effective treatment for leukemia.

💡 They have received funding from FFG Spinoff Fellowship and support from Webnet.

⏭️ The plan is to finish proof of concept studies and spin out the project into a startup company.